The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study

This clinical trial, titled "The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study" (study ID: NCT03910569), is a registry and research study focused on Takotsubo cardiomyopathy — a condition sometimes called "broken heart syndrome" — where the heart temporarily weakens, often triggered by intense physical or emotional stress. The study is collecting clinical and proteomic (protein-level) data to better understand who gets this condition, why it happens, and what can be done to improve outcomes. The study is open to adults aged 18 and older who have received a physician diagnosis of Takotsubo and are willing to share their medical records for research purposes. This is a registry study — participants contribute their medical information and, in some cases, biological samples. There is no experimental treatment involved. You may be eligible if you: - Are 18 years of age or older - Have received a diagnosis of Takotsubo cardiomyopathy from your physician - Are willing to consent to enrollment - Can submit the full medical records needed for study adjudication You may NOT be eligible if you: - Are under 18 years of age - Are unable to provide informed consent - Are unable to provide the necessary medical documentation Talk to your doctor to see if this trial is right for you.